West Pharmaceutical Services Inc.
West Pharmaceutical Services Announces CFO Role Update and Shareholder Meeting Results
Summary
West Pharmaceutical Services, Inc. announced on April 26, 2024, an update to the role of Bernard Birkett, transitioning from Chief Financial and Operations Officer to solely Chief Financial Officer effective May 1, 2024. Additionally, the company's 2024 Annual Meeting of Shareholders was held virtually on April 23, 2024, where shareholders approved several proposals, including amendments to the articles of incorporation and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the 2024 fiscal year.
Profitelligence Alerts
Get alerts for WST
Be first to know when West Pharmaceutical Services Inc. files with the SEC.
Filing Categories
Advertisement
About West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.
Official SEC Documents
Advertisement